← Drug database

Garsun (artesunate)

Orphan
Region
🇪🇺 EU
Active substance
artesunate
Company
B And O Pharm
Status
Application withdrawn
Therapeutic area
Malaria
Designations
Orphan
Application
EMEA/H/C/005718
ATC
P01BE03
Official record
www.ema.europa.eu

Indication

Treatment of severe malaria

Regulatory milestones

No milestones recorded in the last year.

Same substance in other markets

Follow Garsun

Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.